UPDATE: Intra-Cellular Therapies stock soars 83% premarket after FDA approves schizophrenia treatment - MarketWatch

UPDATE: Intra-Cellular Therapies stock soars 83% premarket after FDA approves schizophrenia treatment  MarketWatch

Comments

Popular posts from this blog

Google Doodle honours Terry Fox, on anniversary of first run - Global News